Financial Services -
Banks - Diversified - NYSE - CH
$ 33.8235
0.0305 %
$ 108 B
Market Cap
21.75
P/E
1. INTRINSIC VALUE
Balance Sheet
UBS Group AG
| Current Assets | 410 B |
| Cash & Short-Term Investments | 385 B |
| Receivables | 25.9 B |
| Other Current Assets | 0 |
| Non-Current Assets | 1.15 |
| Long-Term Investments | 1.06 |
| PP&E | 15.5 B |
| Other Non-Current Assets | 82.1 B |
| Current Liabilities | 918 B |
| Accounts Payable | 49 B |
| Short-Term Debt | 14.8 B |
| Other Current Liabilities | 854 B |
| Non-Current Liabilities | 561 B |
| Long-Term Debt | 322 B |
| Other Non-Current Liabilities | 239 B |
EFFICIENCY
Earnings Waterfall
UBS Group AG
| Revenue | 45.8 B |
| Cost Of Revenue | 0 |
| Gross Profit | 45.8 B |
| Operating Expenses | 39 B |
| Operating Income | 6.82 B |
| Other Expenses | 1.89 B |
| Net Income | 4.93 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
UBS Group AG
| Net Income | 4.93 B |
| Depreciation & Amortization | 3.37 B |
| Capital Expenditures | -2.01 B |
| Stock-Based Compensation | 0 |
| Change in Working Capital | -20.8 B |
| Others | 5.81 B |
| Free Cash Flow | 8.79 B |
Wall Street Analysts Price Targets
UBS Group AG
Wall Street analysts predict an average 1-year price target for UBS of $25.7 , with forecasts ranging from
a
low of
$20 to a high of $34 .
UBS Lowest Price Target
Wall Street Target
20 USD
-40.87%
UBS Average Price Target
Wall Street Target
25.7 USD
-24.12%
UBS Highest Price Target
Wall Street Target
34 USD
0.52%
4. DIVIDEND
ANALYSIS
0.00%
DIVIDEND YIELD
0.892 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
UBS Group AG
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
UBS hires tech bankers Larsen, Michlovich from BofA in New York
UBS hired two technology investment bankers in New York from Bank of America, according to a memo seen by Reuters on Thursday.
reuters.com
- 1 week ago
Credit Suisse, SoftBank fight over Greensill losses in $440 mln London lawsuit
Credit Suisse's $440 million London lawsuit against Japan's SoftBank Group Corp kicked off on Thursday over losses linked to Greensill Capital, with the collapsed finance firm's founder Lex Greensill expected to give evidence next week.
reuters.com
- 1 week ago
UBS declares coupon payments on 8 ETRACS Exchange Traded Notes
NEW YORK--(BUSINESS WIRE)--UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the “ETNs”). NYSE Ticker ETN Name and Prospectus Supplementa Coupon Valuation Date Ex-Date Record Date Payment Date Coupon Amount Payment Schedule Current Yield (annualized) b HDLB ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B 5/30/2025 6/.
businesswire.com
- 1 week ago
Why this summer’s market turbulence might just be the buying opportunity you were waiting for
It’s been a stormy start to summer on the markets. Trade tensions are once again flaring, with US President Donald Trump ratcheting up tariffs on steel and aluminium, sending a shiver through global equity markets. China has promised a firm response, while courts in Washington bicker over whether the tariffs are even legal. No surprise, then, that investors have turned cautious. Yet, dig a little deeper and a different picture emerges. According to UBS’s latest market outlook, the overall direction of travel still favours equities over the next 12 months, especially in the United States. Earnings growing Earnings are growing, interest rates could be heading lower again, and even geopolitical posturing might be more bark than bite. UBS’s call is simple: don’t get blown off course by the headlines. Instead, think long term and phase into the market gradually, particularly into high-quality US stocks and sectors driving innovation. That advice comes with good reason. Corporate earnings in the United States rose faster than expected in the first quarter, and UBS has upgraded its full-year forecast for S&P 500 earnings per share to 4%. That might not sound like fireworks, but in a jittery environment, steady profit growth offers solid ground. Even more encouraging, UBS sees 8% earnings growth in 2026, helped along by a pickup in real wages, clearer tax policy, and a return to interest rate cuts by the Federal Reserve. Historical angle There’s also a historical angle worth remembering. Times of high market volatility and low investor confidence (both of which we’re seeing now) have often been followed by strong returns. With the S&P 500 now just shy of its record high, UBS expects it to push higher, hitting 6,400 by next June, up from 5,912 today. But what about all the noise around tariffs? Yes, trade policy is lurching back into confrontational territory, and UBS sees no quick resolution. Still, the base case is that cooler heads will prevail, particularly if markets start to suffer. After all, the Trump administration has shown before that it responds to financial stress. Even with the latest drama, UBS believes the effective US tariff rate will settle around 15% by year-end. That’s not nothing, but it’s manageable. In the meantime, artificial intelligence and other transformational technologies continue to gather pace. Secular growth UBS highlights themes like AI chips, cloud computing, and health care innovation as areas of “secular growth”; in other words, they are rising regardless of the economic cycle. While individual tech stocks may be volatile, the underlying demand remains robust. So, what to do in practice? UBS recommends adding to equities bit by bit rather than trying to time the perfect moment. Think of it as dipping your toe in rather than diving headfirst. For those worried about short-term jolts, strategies focused on preserving capital or diversifying into quality bonds still make sense. The takeaway? This isn’t a time to retreat. It’s a time to plan, pace yourself and, above all, stay invested. Hive Digital Technologies Executive Chairman Frank Holmes joined Steve Darling from Proactive to share significant operational milestones for HIVE Digital Technologies, including surpassing 10 Exahash per second (EH/s) in global Bitcoin mining hashrate and achieving key benchmarks in its high-performance computing (HPC) expansion. Holmes reported that HIVE has added 1 EH/s of mining capacity per week over the last month, bringing its current total to over 10 EH/s. The company is now ahead of schedule in reaching its Phase 1 objective of 11.5 EH/s by the end of June 2025. With a fleet efficiency of 20 Joules per Terahash, HIVE is demonstrating both speed and sustainability in its mining operations. Importantly, Holmes emphasized that this rapid growth is fully funded, giving the company confidence as it continues to scale toward its long-term target of 25 EH/s by the fourth quarter of 2025. This expansion positions HIVE as a serious contender in the global Bitcoin mining sector. Beyond mining, HIVE's HPC subsidiary, Buzz HPC, is also exceeding expectations. The company announced that Buzz HPC has reached a $20 million annualized revenue run-rate from its GPU cloud services—a full month ahead of its original June 2025 target. This milestone reflects the growing demand for GPU-based infrastructure and the effectiveness of HIVE’s strategy in building a complementary business beyond crypto. Buzz HPC now operates with a fleet of over 5,000 high-performance GPUs, enabling the company to serve clients in AI, machine learning, and cloud rendering. The success of Buzz HPC further validates HIVE’s diversified growth model and positions it as a rising player in the cloud infrastructure and AI computing space. #proactiveinvestors #hivedigitaltechnologies # #tsxv #hive #nasdaq #hive #CryptoMining #GreenEnergy #BitcoinMining #ParaguayMining #DataCenter #Exahash #S21Miners #DigitalAssets #ProactiveInvestors
https://www.proactiveinvestors.com
- 1 week ago
Why UBS thinks Dollar General the best retailer for current economic environment
Dollar General Corp (NYSE: DG) rallied more than 15% this morning after reporting better-than-expected earnings for its fiscal Q1. Investors have rewarded the DG share because the retailer raised its full-year guidance as well, indicating Americans are turning to discount stores amidst fears of a slowdown ahead.
invezz.com
- 1 week ago
US recession risk: Is the UK about to catch a cold?
There’s a reason the old cliché about America sneezing still gets wheeled out: it holds up. A new note from UBS flags that recession risks in the United States are quietly ticking higher again, and while nothing’s broken yet, the cracks are starting to show. UBS tracks three main recession indicators: real-world data, credit conditions and the shape of the US yield curve. And all of them are moving in the same direction. Not alarmingly so, but enough to suggest the so-called “soft landing” might not be the final word on the story. Real-world Let’s start with the real economy. UBS’s preferred tracker is built entirely from hard data: production, employment, capital spending, housing, income and consumption. Not a PMI or sentiment survey in sight. This model had flagged trouble back in 2022, only to reverse course in late 2023 as the economy stabilised. But that recovery has since fizzled out. April data, in particular, showed broad-based weakness across all the usual suspects. As a result, UBS now pegs the US recession probability from this model at 46%, up a chunky 12 percentage points in a single month. Troublesome bond market Next up is the yield curve, the time-honoured market signal where investors look at the gap between short- and long-dated Treasury yields. After two years flashing red, that warning light had dimmed. But now it’s glowing again, albeit faintly. According to UBS, the yield curve is currently implying a recession probability of 18%. That’s a far cry from the extremes of last year, but still a notable uptick. Then there’s credit. UBS’s credit-based model, which looks at financial ratios and lending conditions, didn’t fall into the same trap as the yield curve during the false alarm of 2022–24. It held steady. But even that has now started to shift. The model has climbed to a 48 per cent probability—the highest level since the pandemic. Don't press the panic button...yet Put it all together and UBS’s composite gauge puts the US recession risk at 37 per cent. That’s up from 26 per cent in December and, crucially, closing in on the kind of levels that have historically preceded actual downturns. To be clear, no one at UBS is calling a recession yet. The team stresses that the economy started this year on “okay footing”, but warns that “data deterioration could bring back discussion of recession risks”. What’s more, a lot of these shifts happened before the full impact of Donald Trump’s tariffs is likely to be felt. If those start to bite, the probability numbers could push higher still. Still the world engine for demand For those watching from this side of the Atlantic, the message is pretty simple. The US consumer is still the engine of global demand. If they do start to retrench (or if businesses start scaling back investment) there’s little chance the rest of the developed world comes out unscathed. For now, the lights are flashing amber. But it’s worth keeping a close eye on May and June’s data. If the slowdown starts to look more entrenched, expect the market narrative to shift fast, from soft landing to something a lot bumpier. Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) shares rose 7% in afternoon trading after the company received US regulatory approval to expand the use of its lung imaging agent, XENOVIEW, to children as young as six. The decision by the Food and Drug Administration lowers the age threshold from 12, potentially opening access to around one million additional patients. XENOVIEW, used in MRI scans to measure lung ventilation without radiation, will now be available for younger patients with chronic respiratory conditions. Polarean will also roll out new dose delivery bags tailored to paediatric use, along with updated equipment to ensure accurate gas measurements for smaller lungs. The company said the move marks a significant step in broadening access to advanced lung imaging, while also improving the technology’s appeal to hospitals. A targeted launch of the paediatric system will begin later this year, starting with Cincinnati Children’s Hospital. The stock rose 0.085p to 1.36p.
https://www.proactiveinvestors.com
- 1 week ago
UBS' Michael Lasser shares the bull case for Dollar General and Dollar Tree
Michael Lasser, UBS, joins 'Closing Bell Overtime' to talk the bull case for dollar stores.
youtube.com
- 1 week ago
Law firm challenges Swiss court over delay in Credit Suisse AT1 write-down case, filing shows
A Zurich-based law firm has filed a complaint with the Swiss Federal Supreme Court challenging a tribunal's delay in addressing investors' claim on the write-down of Credit Suisse bonds, a legal filing seen by Reuters shows.
reuters.com
- 2 weeks ago
UBS Group's Arm to Divest O'Connor Business to Cantor Fitzgerald
UBS' arm is set to sell its $11B O'Connor unit to Cantor Fitzgerald, sharpening its focus post-Credit Suisse merger amid Swiss capital pressures.
zacks.com
- 2 weeks ago
Why Is UBS (UBS) Up 5% Since Last Earnings Report?
UBS (UBS) reported earnings 30 days ago. What's next for the stock?
zacks.com
- 2 weeks ago
Fifteen UBS Financial Advisors in Arizona Named to Forbes Best-in-State Wealth Advisors List
PHOENIX & SCOTTSDALE, Ariz. & TUCSON, Ariz.--(BUSINESS WIRE)--2025 Forbes Best-In-State Wealth Advisors list names 15 UBS financial advisors from Phoenix; Scottsdale, and Tucson, Arizona.
businesswire.com
- 2 weeks ago
Forty-five UBS Financial Advisors in Southern California and Hawaii Named to Forbes Best-in-State Wealth Advisors List
SAN DIEGO, NEWPORT BEACH, Calif. & HONOLULU--(BUSINESS WIRE)--Financial advisors based in Southern California and Hawaii markets were named to the Forbes Best-In-State Wealth Advisors for 2025.
businesswire.com
- 2 weeks ago
8. Profile
Summary
UBS Group AG UBS
COUNTRY
CH
INDUSTRY
Banks - Diversified
MARKET CAP
$ 108 B
Dividend Yield
0.00%
Description
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank. The Global Wealth Management division offers investment advice and solutions, and lending solutions to ultra high net worth and high net worth clients. This segment also provides estate and wealth planning, investing, philanthropy, corporate and banking, and family advisory services, as well as mortgage, securities-based, and structured lending solutions. The Personal & Corporate Banking division provides personal banking products and services, such as deposits, cards, and online and mobile banking, as well as lending, investments, and retirement services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, trade and export finance, and global custody solutions, as well as transaction banking solutions for payment and cash management. The Asset Management division offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. The Investment Bank division advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; and offers clients differentiated content on major financial markets and securities. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is based in Zurich, Switzerland.
Contact
Bahnhofstrasse 45, Zurich, 8001
https://www.ubs.com
IPO
Date
May 16, 2000
Employees
106789
Officers
Mr. Markus Ronner
Group Chief Compliance & Governance Officer and Member of Group Executive Board
Mr. Iqbal Khan CPA
President of UBS Asia-Pacific, Co-President Global Wealth Management & Member of Group Executive Board
Ms. Beatriz Martin Jimenez
Head NonCore&Legacy&Pres EMEA,GlblTreas & Mem of Ex. Board & GEB Lead for Sus & Imp
Mr. Sergio P. Ermotti
Group Chief Executive Officer & President of the Group Executive Board
Dr. Sabine Keller-Busse
President UBS Switzerland, President of Personal & Corporate Banking and Member of the GEB
Mr. Robert Karofsky
President of UBS Americas, Co-President Global Wealth Management & Member of GEB
Mr. Marco Illy
Co-President of the Investment Bank & Member of Executive Board
Mr. Michael Dargan
Group Chief Operations & Technology Officer and Member of the Executive Board
Mr. Todd Tuckner
Group Chief Financial Officer & Member of Executive Board
Mr. George Athanasopoulos
Co-President Investment Bank & Member of Executive Board